Results 221 to 230 of about 103,562 (296)

AMH specifically targets neuronal AMHR2 to modulate the progression of polycystic ovary syndrome. [PDF]

open access: yesBMC Endocr Disord
Wu K   +8 more
europepmc   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld   +5 more
wiley   +1 more source

Comparative analysis of hormonal and metabolic indices in phenotypic subgroups of polycystic ovary syndrome. [PDF]

open access: yesJ Turk Ger Gynecol Assoc
Savran Üçok B   +6 more
europepmc   +1 more source

First‐trimester preexisting diabetes screening in Medicaid beneficiaries

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Introduction Patients with public insurance have higher rates of pregestational diabetes mellitus (DM) and are less likely to receive preconception care than those with private insurance. First trimester DM screening rates among high‐risk publicly insured pregnant individuals in the United States are unknown.
Zeinab Kassem   +3 more
wiley   +1 more source

Salidroside Ameliorates Polycystic Ovary Syndrome in Mice by Regulating the AKT/NF-κB/NLRP3-HAS2 Axis. [PDF]

open access: yesFood Sci Nutr
Li JH   +14 more
europepmc   +1 more source

Biographical Discovery, Affirmation, and Disruption: Trans and Nonbinary Peoples' Experiences Negotiating Gender and Polycystic Ovary Syndrome

open access: yesSociology of Health &Illness, Volume 48, Issue 4, May 2026.
ABSTRACT Polycystic ovary syndrome (PCOS) is the most common endocrine irregularity in people who are assigned‐female‐at‐birth and are of reproductive age. PCOS causes infertility, irregular periods and hirsutism. Cis women with PCOS describe these symptoms as ‘masculinising,’ which makes them feel inauthentic as women.
Annie McGhee, Ashlyn Arthur
wiley   +1 more source

Kisspeptin as a test of hypothalamic dysfunction in pubertal and reproductive disorders

open access: yesAndrology, Volume 14, Issue 4, Page 1002-1016, May 2026.
Abstract The hypothalamic–pituitary–gonadal axis is regulated by the gonadotropin‐releasing hormone pulse generator in the hypothalamus. This is comprised of neurons that secrete kisspeptin in a pulsatile manner to stimulate the release of GnRH, and, in turn, downstream gonadotropins from the pituitary gland, and subsequently sex steroids and ...
Aureliane C. S. Pierret   +5 more
wiley   +1 more source

Association between history of fertility problems and pregnancy and birth complications: A longitudinal population‐based cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 859-867, May 2026.
In this large cohort of women in Australia, a history of fertility problems was not independently associated with adverse pregnancy outcomes after adjustment. Observed risks were more likely attributable to shared underlying maternal health and lifestyle factors.
Cathryn A. Tully   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy